The European drug authority recommends refusal of marketing authorization due to evidence gaps in quality and efficacy.

In a second surgery, these cells are implanted into the defect in the patient’s knee. While a successful transplant can last 15-20 years, without treatment, the patient can develop ...

For nearly three decades, Mayo Clinic researcher Christopher Evans, Ph.D., has pushed to expand gene therapy beyond its ...

The main finding of this study shows an increase in the size of a cartilage defect between surgeries with increased delays to second-stage autologous chondrocyte implantation/matrix autologous ...

Osteochondral defects (OCDs) can cause damage to cartilage and underlying bone, leading to chronic pain and loss of joint function. Depending on the extent of damage, individuals must undergo ...

In an FDA-observed investigational, new drug, phase 2B study, Anz and his colleagues randomly assigned 81 patients with cartilage defects of the knee greater than 3 cm2 to receive treatment with ...

CHICAGO, Nov. 8, 2018 /PRNewswire/ -- Active people who are struggling with knee pain or knee cartilage abnormalities may benefit from a Rush University Medical Center clinical trial using an ...

Updated: Mar 8, 2017 / 06:26 PM EST (CBS) – Americans of all ages suffer knee pain and stiffness from cartilage loss, but a procedure just approved by the FDA may soon bring relief. Dr.

Damage to knee cartilage and bone can limit mobility and cause chronic pain. Now, researchers have developed an off-the-shelf synthetic ‘plug’ that heals the joint and could be an alternative ...